CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin Lymphoma

NCT07575893 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD30+ CAR T-cells
DRUG: Bendamustin
DRUG: Fludarabine

Sponsor

New York Medical College

Collaborators

[object Object]
[object Object]